This page includes the latest FDA filings for Scpharmaceuticals Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NASDAQ | SCPH | DUNS 079386513 |
Device Company | Device | Date |
---|---|---|
scPharmaceuticals Inc. | Prescription Medication | 2024-08-16 |
scPharmaceuticals Inc. | Prescription Medication | 2024-08-15 |
scPharmaceuticals Inc. | Prescription Medication | 2023-12-01 |
Scpharmaceuticals Inc. | On-body Infusor for Furoscix® | 2023-09-29 |
scPharmaceuticals Inc. | Prescription Medication | 2023-08-25 |
scPharmaceuticals Inc. | Prescription Medication | 2023-06-23 |
scPharmaceuticals Inc. | Prescription Medication | 2023-05-17 |
scPharmaceuticals Inc. | Prescription Medication | 2023-03-06 |
scPharmaceuticals Inc. | Prescription Medication | 2022-12-08 |
scPharmaceuticals Inc. | Prescription Medication | 2022-11-30 |
scPharmaceuticals Inc. | Prescription Medication | 2022-11-22 |
scPharmaceuticals Inc. | Furoscix | 2022-11-14 |
scPharmaceuticals Inc. | Prescription Medication | 2022-11-14 |
SCPHARMACEUTICALS INC | 2022-10-11 18:36:17 |
NCAGE Code | 73Y45 | SCPHARMACEUTICALS INC. |
CAGE Code | 73Y45 | SCPHARMACEUTICALS INC. |
SEC | 0001604950 | scPharmaceuticals Inc. of DELAWARE |